Prince Pharmaceutical Co., Ltd.(TW:6935)
NT$28.00-0.20 (-0.71%)
TW:6935
Prince Pharmaceutical Co., Ltd. Revenue
NT$28.00
At close:-0.20 (-0.71%)
Prince Pharmaceutical Co., Ltd. (6935) Revenue
Prince Pharmaceutical Co., Ltd. Revenue
Prince Pharmaceutical Co., Ltd. had a revenue of 616.64M in the quarter ending Jun 30, 2026, with 1.40%. This bring the company's revenue in the last twelve months to 1.22B, Increased 15.96%. In the fiscal year ending Dec 31, 2025, Prince Pharmaceutical Co., Ltd. had annual revenue of 1.06B with 53.07% growth.
- Revenue (ttm)
- 1.22B
- Revenue Growth
- 53.43%
- P/S Ratio
- 1.26
- Revenue/Employee
- TWD 4,889,819
- Employees
- 216
- Market Cap
- TWD 1.33B
Revenue Chart
Prince Pharmaceutical Co., Ltd. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.06B | 366.18M | 53.07% |
| Dec 31, 2024 | 690.02M | -63.30M | -8.40% |
| Dec 31, 2023 | 753.33M | 40.80M | 5.73% |
| Dec 31, 2022 | 712.53M | 271.45M | 61.54% |
| Dec 31, 2021 | 441.08M | 145.28M | 49.12% |
| Dec 31, 2020 | 295.79M | 46.19M | 18.50% |
| Dec 31, 2019 | 249.61M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.